{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:21:30Z","timestamp":1786407690918,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.prp.2020.153321","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:03:43Z","timestamp":1608228223000},"page":"153321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-1307","authenticated-orcid":false,"given":"Leonard","family":"Naymagon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.prp.2020.153321_bib0005","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2020.153321_bib0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.2019003664","article-title":"Functional and genetic testing in adults with hlh do not reveal a cytotoxicity defect but rather an inflammatory profile","volume":"136","author":"Carvelli","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"25","key":"10.1016\/j.prp.2020.153321_bib0020","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0025","first-page":"100","article-title":"Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients","volume":"93","author":"Li","year":"2014","journal-title":"Bull. Sch. Med. Md"},{"issue":"9","key":"10.1016\/j.prp.2020.153321_bib0030","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00277-020-04083-6","article-title":"A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study","volume":"99","author":"Yoon","year":"2020","journal-title":"Ann. Hematol."},{"issue":"11","key":"10.1016\/j.prp.2020.153321_bib0035","first-page":"1254","article-title":"Fever in sepsis","volume":"78","author":"Schortgen","year":"2012","journal-title":"Minerva Anestesiol."},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/107327481702400212","article-title":"Fever in patients with Cancer","volume":"24","author":"Pasikhova","year":"2017","journal-title":"Cancer Control"},{"issue":"12","key":"10.1016\/j.prp.2020.153321_bib0045","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10067-012-2064-7","article-title":"Febrile conditions in rheumatology","volume":"31","author":"Toth","year":"2012","journal-title":"Clin. Rheumatol."},{"issue":"7 Suppl","key":"10.1016\/j.prp.2020.153321_bib0050","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1097\/CCM.0b013e3181aa6117","article-title":"Fever in the critically ill medical patient","volume":"37","author":"Laupland","year":"2009","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1378\/chest.12-2843","article-title":"Persistent fever in the ICU","volume":"145","author":"Rehman","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.prp.2020.153321_bib0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7861\/clinmedicine.15-3-285","article-title":"Infectious causes of fever of unknown origin","volume":"15","author":"McGregor","year":"2015","journal-title":"Clin. Med. Lond. (Lond)"},{"issue":"7","key":"10.1016\/j.prp.2020.153321_bib0065","first-page":"763","article-title":"Causes of fever in cancer patients (prospective study over 477 episodes)","volume":"14","author":"Toussaint","year":"2006","journal-title":"Support. Care Cancer"},{"issue":"5","key":"10.1016\/j.prp.2020.153321_bib0070","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.berh.2016.10.005","article-title":"Rheumatologic diseases as the cause of fever of unknown origin","volume":"30","author":"Mulders-Manders","year":"2016","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/s-2004-860979","article-title":"Hematologic changes in sepsis and their therapeutic implications","volume":"25","author":"Goyette","year":"2004","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.prp.2020.153321_bib0080","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","article-title":"The management of peripheral blood cytopenias in systemic lupus erythematosus","volume":"49","author":"Hepburn","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0974-2727.78555","article-title":"Pancytopenia: a clinico hematological study","volume":"3","author":"Gayathri","year":"2011","journal-title":"J. Lab. Physicians"},{"key":"10.1016\/j.prp.2020.153321_bib0090","series-title":"Holland-Frei Cancer Medicine","author":"Bast","year":"2017"},{"key":"10.1016\/j.prp.2020.153321_bib0095","series-title":"Haematology in Critical Care","author":"Thachil","year":"2014"},{"key":"10.1016\/j.prp.2020.153321_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JBM.S90693","article-title":"Acquired hypofibrinogenemia: current perspectives","volume":"7","author":"Besser","year":"2016","journal-title":"J. Blood Med."},{"issue":"12","key":"10.1016\/j.prp.2020.153321_bib0105","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0110","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.1111537","article-title":"Mechanisms of triglyceride accumulation in activated macrophages","volume":"92","author":"Feingold","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.prp.2020.153321_bib0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George","year":"2014","journal-title":"J. Blood Med."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","article-title":"Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins","volume":"30","author":"Cabana","year":"1989","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/07853899009147277","article-title":"Lipoproteins and acute phase response during acute infection. Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins","volume":"22","author":"Sammalkorpi","year":"1990","journal-title":"Ann. Med."},{"key":"10.1016\/j.prp.2020.153321_bib0135","series-title":"Endotext. South Dartmouth (MA)","article-title":"The effect of inflammation and infection on lipids and lipoproteins","author":"Feingold","year":"2000"},{"key":"10.1016\/j.prp.2020.153321_bib0140","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874192401105010064","article-title":"Dyslipidaemia in rheumatological autoimmune diseases","volume":"5","author":"Toms","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0145","first-page":"421","article-title":"The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity","volume":"6","author":"Harris","year":"2000","journal-title":"J. Endotoxin Res."},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0150","first-page":"428","article-title":"Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group","volume":"15","author":"Connelly","year":"1999","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.prp.2020.153321_bib0155","series-title":"StatPearls","article-title":"Hypertriglyceridemia","author":"Karanchi","year":"2020"},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0377-1237(17)31008-0","article-title":"Lipid profile in normal healthy children","volume":"50","author":"Chandar","year":"1994","journal-title":"Med. J. Armed Forces India"},{"issue":"1009","key":"10.1016\/j.prp.2020.153321_bib0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1259\/bjr\/31542964","article-title":"Spleen in haematological malignancies: spectrum of imaging findings","volume":"85","author":"Saboo","year":"2012","journal-title":"Br. J. Radiol."},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00292-008-0967-5","article-title":"[Functional splenic pathology and differential diagnosis in splenectomy]","volume":"29","author":"Marx","year":"2008","journal-title":"Pathologe"},{"issue":"11","key":"10.1016\/j.prp.2020.153321_bib0175","doi-asserted-by":"crossref","first-page":"e0186674","DOI":"10.1371\/journal.pone.0186674","article-title":"Splenomegaly - Diagnostic validity, work-up, and underlying causes","volume":"12","author":"Curovic Rotbain","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0180","first-page":"88","article-title":"Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients","volume":"169","author":"O\u2019Reilly","year":"1998","journal-title":"West. J. Med."},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/joim.12104","article-title":"HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C(high) inflammatory monocytes in murine sepsis survivors","volume":"274","author":"Valdes-Ferrer","year":"2013","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.prp.2020.153321_bib0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0049-0172(97)80013-3","article-title":"Splenic involvement in rheumatic diseases","volume":"27","author":"Fishman","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.prp.2020.153321_bib0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1874312901408010129","article-title":"Felty\u2019s syndrome, insights and updates","volume":"8","author":"Owlia","year":"2014","journal-title":"Open Rheumatol. J."},{"issue":"9","key":"10.1016\/j.prp.2020.153321_bib0200","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2020.153321_bib0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/blood-2017-02-768580","article-title":"Ferritin is secreted via 2 distinct nonclassical vesicular pathways","volume":"131","author":"Truman-Rosentsvit","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0210","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","article-title":"Serum ferritin: past, present and future","volume":"1800","author":"Wang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.prp.2020.153321_bib0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ajcp\/aqw053","article-title":"Extreme hyperferritinemia: causes and impact on diagnostic reasoning","volume":"145","author":"Sackett","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0220","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2095","article-title":"Screening for Iron deficiency in early childhood using serum ferritin in the primary care setting","volume":"142","author":"Oatley","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000206567","article-title":"Serum ferritin in evaluation of iron status in children","volume":"71","author":"Madanat","year":"1984","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","article-title":"Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting","volume":"102","author":"Saeed","year":"2015","journal-title":"Int. J. Hematol."},{"issue":"10","key":"10.1016\/j.prp.2020.153321_bib0235","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","article-title":"Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis","volume":"96","author":"Otrock","year":"2017","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.prp.2020.153321_bib0240","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0245","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/ejh.13391","article-title":"Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis","volume":"104","author":"Naymagon","year":"2020","journal-title":"Eur. J. Haematol."},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0250","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","article-title":"Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review","volume":"13","author":"Bien","year":"2008","journal-title":"Biomarkers"},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0260","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00277-017-2993-y","article-title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","volume":"96","author":"Lin","year":"2017","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.prp.2020.153321_bib0265","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/cs0970529","article-title":"Markers of systemic inflammation predicting organ failure in community-acquired septic shock","volume":"97","author":"Takala","year":"1999","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ecco-jcc\/jjx124","article-title":"Sepsis markers soluble IL-2 receptor and soluble CD14 subtype as potential biomarkers for complete mucosal healing in patients with inflammatory bowel disease","volume":"12","author":"Hosomi","year":"2018","journal-title":"J. Crohns Colitis"},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0275","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1701163","article-title":"Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation","volume":"21","author":"Foley","year":"1998","journal-title":"Bone Marrow Transplant."},{"issue":"2 Pt 1","key":"10.1016\/j.prp.2020.153321_bib0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0190-9622(98)70597-3","article-title":"Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma","volume":"38","author":"Vonderheid","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"issue":"11","key":"10.1016\/j.prp.2020.153321_bib0285","doi-asserted-by":"crossref","first-page":"e78730","DOI":"10.1371\/journal.pone.0078730","article-title":"Clinical significance of sIL-2R levels in B-cell lymphomas","volume":"8","author":"Yoshida","year":"2013","journal-title":"PLoS One"},{"issue":"5\u20136","key":"10.1016\/j.prp.2020.153321_bib0290","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/10428199209049799","article-title":"Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukemia","volume":"7","author":"Barak","year":"1992","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0295","first-page":"410","article-title":"Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia","volume":"34","author":"Moon","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF02231527","article-title":"Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus","volume":"12","author":"Sawada","year":"1993","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0305","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/ard.53.4.235","article-title":"Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study","volume":"53","author":"Spronk","year":"1994","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.prp.2020.153321_bib0310","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.141.8.2612","article-title":"Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition","volume":"141","author":"Symons","year":"1988","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2020.153321_bib0315","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/1346-8138.13792","article-title":"Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement","volume":"44","author":"Thi Hong Nguyen","year":"2017","journal-title":"J. Dermatol."},{"issue":"26","key":"10.1016\/j.prp.2020.153321_bib0320","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/bloodadvances.2017012310","article-title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","volume":"1","author":"Hayden","year":"2017","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.prp.2020.153321_bib0325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ejh.13433","article-title":"Soluble Interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis (HLH)","volume":"105","author":"Naymagon","year":"2020","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.prp.2020.153321_bib0330","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00043426-199611000-00002","article-title":"Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis","volume":"18","author":"Egeler","year":"1996","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0335","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13023-020-01390-z","article-title":"Genotype characteristics and immunological indicator evaluation of 311 hemophagocytic lymphohistiocytosis cases in China","volume":"15","author":"Zhang","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0340","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.CCM.0000127779.24232.15","article-title":"Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients--a postmortem clinicopathologic analysis","volume":"32","author":"Strauss","year":"2004","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0345","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0046-8177(88)80177-1","article-title":"Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations","volume":"19","author":"Suster","year":"1988","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0350","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00428-014-1592-8","article-title":"Risk factor analysis for bone marrow histiocytic hyperplasia with hemophagocytosis: an autopsy study","volume":"465","author":"Inai","year":"2014","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.prp.2020.153321_bib0355","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0002-9343(97)00136-8","article-title":"Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor","volume":"103","author":"Francois","year":"1997","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.prp.2020.153321_bib0360","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.amjmed.2014.04.034","article-title":"Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients","volume":"127","author":"Riviere","year":"2014","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0365","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2020.153321_bib0370","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0375","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","article-title":"Performances of the H-Score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients","volume":"145","author":"Debaugnies","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2020.153321_bib0380","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ."},{"issue":"10","key":"10.1016\/j.prp.2020.153321_bib0385","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","article-title":"Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"78","author":"Minoia","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0390","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13054-020-02941-3","article-title":"Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore","volume":"24","author":"Knaak","year":"2020","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.prp.2020.153321_bib0395","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1177\/0885066619837139","article-title":"The performance of diagnostic criteria for hemophagocytic lymphohistiocytosis in critically ill patients","volume":"35","author":"Meena","year":"2020","journal-title":"J. Intensive Care Med."},{"issue":"6","key":"10.1016\/j.prp.2020.153321_bib0400","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.prp.2020.153321_bib0405","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13054-020-02878-7","article-title":"Faguer S, group Ts. IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome","volume":"24","author":"Dufranc","year":"2020","journal-title":"Crit. Care"},{"issue":"21","key":"10.1016\/j.prp.2020.153321_bib0410","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.prp.2020.153321_bib0415","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol."},{"issue":"19","key":"10.1016\/j.prp.2020.153321_bib0420","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820321762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:44:07Z","timestamp":1759733047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820321762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":84,"alternative-id":["S0344033820321762"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153321","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we truly diagnose adult secondary hemophagocytic lymphohistiocytosis (HLH)? A critical review of current paradigms","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153321"}}